• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Rabbit anti-Human IFI35 Polyclonal Antibody

The antibody against IFI35 was raised in Rabbit using the recombinant fusion protein containing a sequence corresponding to amino acids 1-288 of human IFI35 (NP_005524.2) as the immunogen. The polyclonal antibody exists as a isotype IgG, by affinity purification. This antibody has been validated on WB, ELISA.

ADA-08746A

The antibody against IFI35 was raised in Rabbit using the recombinant fusion protein containing a sequence corresponding to amino acids 1-288 of human IFI35 (NP_005524.2) as the immunogen. The polyclonal antibody exists as a isotype IgG, by affinity purification. This antibody has been validated on WB, ELISA.

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ADA-08746A ClonalityPolyclonal
Host SpeciesRabbitTarget NameIFI35
Target SynonymsIFP35; IFI35FormLiquid
Species ReactivityHuman, MouseIsotypeIgG
Storage Buffer50% Glycerol, PBS with 0.01% thimerosal, pH7.3.Purification MethodAffinity purification
Positive SamplesHeLa, A-431, HepG2ApplicationELISA, WB

Immunogen Information


Immunogen DescriptionRecombinant fusion protein containing a sequence corresponding to amino acids 1-288 of human IFI35 (NP_005524.2).Target SpeciesHuman
Uniprot IDP80217Immunogen Sequence
Background Information
  • Uniprot Id

    P80217

  • Target Species

    Human

  • Target Name

    IFI35

  • Target Full Name

    Interferon-induced 35 kDa protein

  • Target Function

    Acts as a signaling pathway regulator involved in innate immune system response. In response to interferon IFN-alpha, associates in a complex with signaling pathway regulator NMI to regulate immune response; the complex formation prevents proteasome-mediated degradation of IFI35 and correlates with IFI35 dephosphorylation. In complex with NMI, inhibits virus-triggered type I interferon/IFN-beta production. In complex with NMI, negatively regulates nuclear factor NF-kappa-B signaling by inhibiting the nuclear translocation, activation and transcription of the NF-kappa-B subunit p65/RELA, resulting in the inhibition of endothelial cell proliferation, migration and re-endothelialization of injured arteries. Beside its role as an intracellular signaling pathway regulator, also functions extracellularly as damage-associated molecular patterns (DAMPs) to promote inflammation when actively released by macrophage to the extracellular space during cell injury and pathogen invasion. Macrophage-secreted IFI35 activates NF-kappa-B signaling in adjacent macrophages through Toll-like receptor 4/TLR4 activation, thereby inducing NF-kappa-B translocation from the cytoplasm into the nucleus which promotes the release of proinflammatory cytokines

  • Target Subcellular Location

    Cytoplasm. Nucleus. Secreted.

  • Target Protein Families

    NMI family

  • Target Tissue Specificity

    Expressed in a wide range of cell types, including fibroblasts, macrophages, and epithelial cells.

  • Target Synonyms

    FLJ21753; IFI 35; Ifi-35; Ifi35; IFP 35; IFP35; IN35; IN35_HUMAN; Interferon induced 35 kDa protein; Interferon-induced 35 kDa protein; OTTHUMP00000236626; OTTHUMP00000236627

Inquire Rabbit anti-Human IFI35 Polyclonal Antibody Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification